New computer model predicts prostate cancer progression
Can't see this email? View it online
   
  December 13, 2018  
  Prostate Cancer  
  The latest prostate cancer news from News Medical  
 New computer model predicts prostate cancer progressionNew computer model predicts prostate cancer progression
 
An international team of cancer researchers from Denmark and Germany have used cancer patient data to develop a computer model that can predict the course of disease for prostate cancer.
 
   New study confirms effectiveness of PSA screening in reducing prostate cancer deathsNew study confirms effectiveness of PSA screening in reducing prostate cancer deaths
 
A new study has confirmed the effectiveness of Prostate-specific Antigen screening in reducing prostate cancer mortality.
 
   Surgical treatment unnecessary for many prostate cancer patientsSurgical treatment unnecessary for many prostate cancer patients
 
Otherwise healthy men with advanced prostate cancer may benefit greatly from surgery, but many with this diagnosis have no need for it. These conclusions were reached by researchers after following a large group of Scandinavian men with prostate cancer for 29 years. The results are now published in The New England Journal of Medicine.
 
 Men with inflammatory bowel disease have higher prostate cancer risk
 
Men with inflammatory bowel disease have higher prostate cancer riskMen with inflammatory bowel disease have four to five times higher risk of being diagnosed with prostate cancer, reports a 20-year study from Northwestern Medicine.
 
 
 Faster, cheaper test has potential to enhance prostate cancer evaluation
 
Faster, cheaper test has potential to enhance prostate cancer evaluationFor men newly diagnosed with prostate cancer or patients previously treated, the risk of metastasis is a crucial determinant of whether to choose conservative management or undergo further treatment.
 
 
 Whole-body imaging PET/MRI offers information to guide treatment options for prostate cancer
 
Whole-body imaging PET/MRI offers information to guide treatment options for prostate cancerNew research on prostate cancer staging shows that PSMA-targeted PET/MRI performs equally as well as currently used predictive tools to determine the risk for advanced disease.
 
 
 LDR brachytherapy for treating early-stage prostate cancer lacks conclusive data
 
LDR brachytherapy for treating early-stage prostate cancer lacks conclusive dataInterstitial brachytherapy uses slightly radioactive particles implanted into the prostate to deliver radiation directly to the tumour (low-dose-rate, LDR).